novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide cuts heart by 57% versus rival Lilly weight-loss drug in study Wegovy Outperforms Tirzepatide in Reducing
Description
Compounded drugs are not regulatory approved, despite having similar active ingredients
Unlock the full potential of Tirzepatide for weight loss
Scientists have now created long-lasting GLP-1 drugs that can be used to treat type 2 diabetes, obesity, and a range of other conditions
Two prominent options arePep, a GLP-1-specific tracking app, andWeightWatchers (WW), a long-standing weight management platform
Each serving delivers 78 billion CFUs from a broad range of beneficial strains including Lactobacillus, Bifidobacterium, Akkermansia muciniphila and Christensenella minuta, known for their contribution to a balanced gut microbiome
Cognitive Support: Bolsters memory and cognitive function
